Sanofi To Challenge Acomplia Decision By German Court
"Sanofi-Aventis says that it intends to challenge in the courts the decision made by the German Ministry of Health which states that the firm's anti-obesity drug Acomplia will not be reimbursed.
The Ministry of Health has upheld a recommendation from the German Federal Joint Committee, the G-BA, which said in October that it believes funding treatment with Acomplia (rimonabant) is inappropriate because it is a 'lifestyle' drug, a viewpoint which Sanofi disagrees with vigorously.
The French drugmaker has argued that Acomplia should be covered because it helps lower the risk of developing diabetes and cardiovascular disease, in addition to aiding weight loss. Indeed, Sanofi recently presented data from a Phase III trial of Acomplia which shows that treatment-naive patients with type 2 diabetes who received the drug experienced significant improvements in blood glucose control and weight loss, compared to those who took placebo."
acomplia
rimonabant
accomplia
2 Comments:
After taking this drug it made me complete and happy because I lost some weight by using this. I'm so happy with this product. i'll surely recommend this drug to all of those who want to loose weight
After taking this drug it made me complete and happy because I lost some weight by using this. I'm so happy with this product. i'll surely recommend this drug to all of those who want to loose weight. … I got Acomplia from www.medsheaven.com...
Post a Comment
<< Home